Literature DB >> 15242724

Anaphylactoid and adverse reactions to radiocontrast agents.

John B Hagan1.   

Abstract

Over the past 75 years, radiocontrast agents have provided numerous diagnostic and therapeutic advances. The benefits of these agents must be weighed against the potential risks for each individual undergoing radiologic tests. This summary is intended to be a guide for the allergy and immunology specialist to direct him or her to the current literature regarding adverse reactions to traditional and less commonly used radiologic contrast agents.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15242724     DOI： 10.1016/j.iac.2004.03.005

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN： 0889-8561            Impact factor:   3.479


  6 in total

Review 1.  Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.

Authors:  Ezekiel Maloney; Ramesh S Iyer; Grace S Phillips; Shina Menon; John J Lee; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 2.  Adverse reactions to iodinated contrast media.

Authors:  Wendy Bottinor; Pritam Polkampally; Ion Jovin
Journal:  Int J Angiol       Date:  2013-09

3.  The communication of the radiation risk from CT in relation to its clinical benefit in the era of personalized medicine: part 2: benefits versus risk of CT.

Authors:  Sjirk J Westra
Journal:  Pediatr Radiol       Date:  2014-10-11

4.  Can the lower rate of CT- or MRI-related adverse drug reactions to contrast media due to stricter limitations on patients undergoing contrast-enhanced CT or MRI?

Authors:  Takahiro Maeda; Masafumi Oda; Shinji Kito; Tatsurou Tanaka; Nao Wakasugi-Sato; Shinobu Matsumoto-Takeda; Takaaki Joujima; Yuichi Miyamura; Koichi Kiyota; Kensuke Tsutsumi; Yasuhiro Morimoto
Journal:  Dentomaxillofac Radiol       Date:  2019-10-23       Impact factor: 2.419

5.  Risk factors for adverse reactions from contrast agents for computed tomography.

Authors:  Daiki Kobayashi; Osamu Takahashi; Takuya Ueda; Gautam A Deshpande; Hiroko Arioka; Tsuguya Fukui
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-30       Impact factor: 2.796

6.  Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.

Authors:  Naoto Fujiwara; Ryosuke Tateishi; Masaaki Akahane; Masataka Taguri; Tatsuya Minami; Shintaro Mikami; Masaya Sato; Koji Uchino; Kouji Uchino; Kenichiro Enooku; Yuji Kondo; Yoshinari Asaoka; Noriyo Yamashiki; Tadashi Goto; Shuichiro Shiina; Haruhiko Yoshida; Kuni Ohtomo; Kazuhiko Koike
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.